Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 6.93%15.16B | -0.65%14.18B | 4.79%3.44B | -3.94%3.76B | -7.99%3.46B | 6.19%3.52B | 17.54%14.27B | 4.24%3.28B | 24.15%3.91B | 36.18%3.76B |
| Cost of revenue | -5.17%12.66B | 5.41%13.35B | 6.55%3.28B | -5.35%3.23B | 6.74%3.38B | 15.04%3.46B | 16.46%12.66B | 6.85%3.07B | 22.00%3.41B | 22.24%3.17B |
| Gross profit | 201.51%2.5B | -48.37%829.98M | -21.00%165.55M | 5.62%529.74M | -86.51%80.14M | -81.95%54.55M | 26.84%1.61B | -23.21%209.56M | 41.09%501.54M | 247.42%594.29M |
| Operating expense | 18.40%1.13B | 3.13%954.25M | 0.30%221.18M | 5.74%259.43M | 8.55%248.06M | -2.31%225.58M | 9.27%925.31M | 0.33%220.53M | 26.13%245.36M | 12.14%228.52M |
| Operating profit | 1,204.55%1.37B | -118.21%-124.27M | -406.90%-55.63M | 5.51%270.31M | -145.91%-167.91M | -339.80%-171.03M | 62.23%682.29M | -120.68%-10.98M | 59.16%256.18M | 1,217.93%365.77M |
| Net non-operating interest income (expenses) | -5.32%-451.88M | 7.48%-429.04M | -2.52%-151.94M | 22.14%-75.93M | 9.00%-108.23M | 6.18%-92.95M | 0.88%-463.72M | -5.81%-148.2M | 18.72%-97.52M | -7.57%-118.93M |
| Non-operating interest income | 7,888.95%40.5M | 1,648.28%507K | -24.97%-49.06M | 80.25%30.61M | 95.32%1.13M | -17.94%17.83M | -91.55%29K | -96.26%-39.26M | 406.14%16.98M | -23.68%577K |
| Non-operating interest expense | 14.63%492.39M | -7.38%429.55M | -5.57%102.88M | -6.95%106.53M | -8.49%109.36M | -8.30%110.78M | -0.94%463.75M | -9.26%108.94M | -7.16%114.5M | 7.36%119.51M |
| Net investment income | 31.26%64.49M | 954.17%49.14M | -742.58%-210.68M | 1,080.10%253.73M | -274.11%-11.67M | 298.59%17.75M | -76.76%4.66M | 36.74%32.79M | -474.40%-25.89M | 138.17%6.7M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 797.33%6.17B | -31.99%688.01M | 678,764.71%577.04M | 0 | 1,037.90%110.98M | 0 | -28.20%1.01B | 100.24%85K | 15,036.68%995.69M | -99.31%9.75M |
| Less:Other special charges | -797.33%-6.17B | 31.99%-688.01M | -678,764.71%-577.04M | --0 | ---- | ---- | 28.20%-1.01B | -100.24%-85K | -15,036.68%-995.69M | 99.31%-9.75M |
| Other non-operating income (expenses) | -345.57%-7.12M | -81.10%2.9M | 151.06%2.06M | -96.10%703K | 26.83%-270K | -76.27%412K | 116.66%15.35M | -141.83%-4.03M | 728.77%18.01M | -45.85%-369K |
| Income before tax | 3,729.92%7.15B | -85.06%186.74M | 223.42%160.85M | -60.85%448.81M | -167.36%-177.11M | -750.39%-245.81M | -9.98%1.25B | -46.18%-130.33M | 2,752.71%1.15B | -79.29%262.92M |
| Income tax | 4,988.37%2.04B | -89.28%40.1M | 177.17%30.8M | -60.33%137.66M | -173.68%-53.99M | -1,090.81%-74.38M | -26.05%374.12M | -22.34%-39.92M | 2,211.96%347M | -84.14%73.28M |
| Net income | 3,385.83%5.11B | -83.26%146.64M | 243.83%130.05M | -61.08%311.15M | -164.92%-123.11M | -656.55%-171.44M | -0.77%876.04M | -59.93%-90.41M | 3,074.90%799.47M | -76.51%189.64M |
| Net income continuous operations | 3,385.83%5.11B | -83.26%146.64M | 243.83%130.05M | -61.08%311.15M | -164.92%-123.11M | -656.55%-171.44M | -0.77%876.04M | -59.93%-90.41M | 3,075.03%799.47M | -76.51%189.64M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 3,385.83%5.11B | -83.26%146.64M | 243.83%130.05M | -61.08%311.15M | -164.92%-123.11M | -656.55%-171.44M | -0.77%876.04M | -59.93%-90.41M | 3,074.90%799.47M | -76.51%189.64M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 3,385.83%5.11B | -83.26%146.64M | 243.83%130.05M | -61.08%311.15M | -164.92%-123.11M | -656.55%-171.44M | -0.77%876.04M | -59.93%-90.41M | 3,074.90%799.47M | -76.51%189.64M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 3,386.70%668.4 | -83.26%19.17 | 243.82%17 | -61.09%40.68 | -164.91%-16.09 | -657.43%-22.42 | -0.77%114.55 | -59.95%-11.82 | 3,077.51%104.54 | -76.52%24.79 |
| Diluted earnings per share | 3,386.70%668.4 | -83.26%19.17 | 243.80%17 | -61.09%40.68 | -164.94%-16.0981 | -657.43%-22.42 | -0.77%114.55 | -59.93%-11.8223 | 3,077.41%104.5368 | -76.52%24.79 |
| Dividend per share | 0.00%20 | 0.00%20 | 0.00%20 | 0 | 0 | 0 | 0.00%20 | 0.00%20 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |